SPRING INTO HOPE!
Don’t miss the free, weekend-long conference that brings together hundreds of people living with lung cancer, survivors, and care partners to make new friends, inspire hope, and learn from experts in the field.
Meet the HOPE Summit Ambassadors!
A special team of HOPE Summit alumni is available before and during the event to help first-time attendees feel welcome and navigate the conference. They can answer your questions, share their experiences, make introductions, and help you get the most out of your HOPE Summit experience.
Get to know this group of dedicated volunteers before HOPE Summit weekend. You can connect personally with an Ambassador by emailing hope@lungevity.org, and stay tuned to @lungevity on Instagram to watch for their videos.
LUNGevity’s Fall Science Meeting—Accelerating Progress in Lung Cancer Research
LUNGevity’s Annual Fall Science Meeting brings together an extraordinary group of thought leaders—renowned experts in lung cancer research from our esteemed Scientific Advisory Board (SAB) and LUNGevity awardees. This event is a pivotal moment in the fight against lung cancer, as our awardees present their groundbreaking LUNGevity-funded research projects to gain invaluable insights and feedback from the SAB and patient-partners.
In our most recent meeting, we reviewed 31 transformative research awards that span the entire lung cancer continuum, from early detection to innovative treatments. We are inspired by the remarkable strides being made and excited by the potential to change lives.
This meeting offers an exclusive opportunity for researchers to:
- Reconnect with peers in a collaborative, intimate setting, sparking new ideas and fostering partnerships
- Gain insights into cutting-edge work being done across the lung cancer research community—truly inspiring and thought-provoking.
- Forge impactful collaborations with some of the world’s leading lung cancer scientists
- Receive direct feedback on their research from the preeminent experts of the LUNGevity Scientific Advisory Board
Learn more about the critical work happening at LUNGevity and the impactful research we are proud to support.
LUNGevity’s Commitment to Advocacy and Research in Uncertain Times
Last week LUNGevity issued a statement reaffirming our commitment to the lung cancer community in light of recent government actions related to healthcare and their possible impact on lung cancer diagnoses, research, treatment, and ongoing care. Read the statement here.
If you would like to help, please consider making a donation.
Conversations that Count
TUESDAY, APRIL 15 | 12-1 PM ET
LUNGevity's monthly Conversations that Count series gives you a seat at the table as top experts engage in critical discussions.
On Tuesday, April 15, Claudia M. Hardy, MPA, and Angela G. Williams, MHERC, join us to share their 15 years of experience building a community-academic infrastructure to improve cancer screening and conduct community-based research to address disparities.
In case you missed it last month, Cardinale B. Smith, MD, PhD, Chief Medical Officer at Memorial Sloan Kettering Cancer Center, presented her research around building lasting relationships between communities and researchers. You can read a summary or watch the full presentation here.
Tackling Drug-Tolerant Cells in EGFR+ Lung Cancer
May 6, 2 pm ET on Facebook Live
Join us for an engaging Facebook Live to discover the secrets of drug-tolerant persister cells (DTPCs)—those sneaky survivors that resist treatment and fuel cancer's return.
Christine Lovly, MD, PhD, shares her groundbreaking research, funded by the EGFR Resisters. Jill Feldman, co-founder of the EGFR Resisters, and LUNGevity’s Upal Basu Roy, PhD, MPH, join for an insightful discussion. Learn how we're tackling these elusive cells and paving the way for better treatments.
LUNGevity was proud to take part again this year in the One Voice Against Cancer (OVAC) Grassroots Lobby Day in Washington, DC, on March 5-6. This powerful event united over 80 passionate advocates—including survivors, caregivers, researchers, and healthcare professionals—to push for stronger federal investments in cancer research and prevention.
For the second consecutive year, LUNGevity provided travel scholarships to support the participation of lung cancer advocates in this event. Courtney Welch, an oncology nurse practitioner and lung cancer advocate from Colorado, shared her experience in a recent blog post.
Big News: Team LUNGevity Is Expanding to Three New International Marathons! 🌍
For the first time ever, Team LUNGevity has guaranteed race entries to three more in-demand international marathons:
📍 Irish Life Dublin Marathon
October 26, 2025
📍 Athens Marathon
November 9, 2025
📍 Valencia Marathon
December 7, 2025
This exciting expansion means we're now racing to stop lung cancer in six countries—Germany, France, Australia, Ireland, Greece, and Spain—in addition to the US!
👟If you’re a runner …
✈️ If you love to travel …
🎯 If a marathon is on your bucket list …
🔬 If you're passionate about progress in lung cancer …
This is your chance! Join us for an unforgettable experience while making a difference. Learn more at www.teamlungevity.org.
Springing into Action for Better Health 🌱
LUNGevity’s first-ever “Spring into Screening” Lunch & Learn was in full bloom on Saturday, March 22, at the Community of Hope Conway Health and Resource Center in Ward 8 of Washington, DC.
The event brought together hospitals and nonprofits from across DC to empower the community with essential information and resources about breast, colorectal, lung, and prostate cancer screenings. Attendees didn’t just learn—they took action! Many signed up for mammograms, lung cancer screening, and prostate cancer screening, while others ordered FIT colorectal cancer screening tests and took advantage of on-site blood pressure screenings and mammograms.
Expert speakers debunked common myths and shared lifesaving facts about early detection, making sure everyone walked away informed and inspired. Generous prizes were donated by Giant Foods and the Washington Commanders, and a delicious lunch was provided by Busboys & Poets.
There is power in early detection. It gives us the chance to take action when it matters most—early—when more treatment options are available. But the true power of early detection isn’t just in the medical results—it’s in the moments, the milestones, and the time it gives us with the people we love. Together, we’re making that possible—one conversation, one screening at a time. Stay tuned for more ways to get involved.
Photos courtesy of Florencio V. Paraon.
A huge thank you to our incredible partners for making this event possible:
- DC Health
- DC Mayor’s Office on Women’s Policy and Initiatives
- George Washington University Hospital
- Johns Hopkins Sidney Kimmel Cancer Center
- MedStar Health
- American Lung Cancer Screening Initiative
- Brem Foundation to Defeat Breast Cancer
- Colorectal Cancer Alliance
- Community of Hope
- It’s in the Genes
- Ralph Lauren Center for Cancer Prevention
How Do We Treat Early-Stage NSCLC in 2025?
Roughly 20% of lung cancer is diagnosed as early-stage disease, and researchers have been working to improve treatment options for these patients—with significant success.
Last September, as part of LUNGevity’s International Lung Cancer Survivorship Conference, we hosted a session on the progress in treating early-stage non-small cell lung cancer (NSCLC) with Dr. Jarushka Naidoo of Beaumont RCSI Cancer Centre in Ireland.
Dr. Naidoo spoke about:
- Treatment approaches based on stage
- Combining surgery with chemotherapy, immunotherapy, and targeted therapy
- Treating NSCLC before surgery
- Scientific progress in recent years
LUNGevity's Part in the Quest to Conquer Cancer Cachexia
Each year, millions of people with cancer experience cachexia, or wasting, characterized by significant unintended weight loss. This complex syndrome lessens their quality of life and makes it harder for them to endure cancer treatments.
General physical wasting and malnutrition usually associated with chronic disease
Since 2022, LUNGevity has been a key player in a $25 million international network, Team CANCAN, dedicated to understanding and treating cachexia.
Team CANCAN (Cancer Cachexia Action Network), which includes experts from 14 institutions in the US and UK, is running two major clinical studies, UNCOVER and LOTUS-CC, focusing on lung, colorectal, and pancreatic cancer to identify early signs of cachexia and improve outcomes.
Team CANCAN is funded by Cancer Grand Challenges, a global research initiative to help overcome the toughest challenges in cancer. LUNGevity participated in the Cancer Grand Challenges Summit in Boston, held from March 4-7, 2025. This prestigious event gathers the brightest minds in cancer research from around the world, all united in their mission to solve some of the biggest issues in the field—including cachexia.
LUNGevity is proud to be part of this crucial work, supporting individuals with lung cancer at risk for cachexia. Learn more about Team CANCAN’s work and patient resources here.
LUNGevity is transforming what it means to be diagnosed and live with lung cancer. Support our mission by making a tax-deductible donation today.
